Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Medtronic | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The PROSTIM study is an ongoing prospective, multicentric and observational clinical study. Patients are recruited in three different centers in Eastern Belgium from May 2018 onwards. This real-world data collection approaches the outcome assessment of daily medical practice. A hierarchical cluster analysis is used to identify significant patient clusters based on the Visual Analogue Scale (VAS), Oswestry disability index (ODI), Pain Vigilance and Awareness Questionnaire (PVAQ), Pain Catastrophizing Scale (PCS) and EuroQol with five dimensions for health-related quality of life (EQ-5D). Patient clusters will be assessed on the change in biopsychosocial variables after six weeks, three and twelve months. Secondary outcomes include the comparison of pain medication use, SCS parameters, treatment satisfaction and return to work.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Spinal cord stimulation | Device | Eligible patients will undergo a SCS trial period for three weeks (as legally defined by the reimbursement authorities). The leads can be placed both surgically of percutaneously with an external trial stimulator. Surgical implantation of an implanted pulse generator (IPG) is performed if the patient achieves at least 50% pain reduction and a reduced pain medication use (reimbursement requirements) during the trial period. Subsequently, the implanted devices are programmed to the optimal parameters in collaboration with a nurse specialized in SCS treatment. The patients are educated on the use of the patient programmer. |
| Measure | Description | Time Frame |
|---|---|---|
| Back pain | Visual analogue scale back (0-10) | 3 weeks |
| Leg pain | Visual analogue scale back (0-10) | 3 weeks |
| Back pain | Visual analogue scale back (0-10) | 6 months |
| Leg pain | Visual analogue scale back (0-10) | 6 months |
| Back pain | Visual analogue scale back (0-10) | 12 months |
| Leg pain | Visual analogue scale back (0-10) | 12 months |
| Disability | Oswestry Disability Index, ODI (0-100) | 3 weeks |
| Disability | Oswestry Disability Index, ODI (0-100) | 6 months |
| Disability | Oswestry Disability Index, ODI (0-100) | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Pain medication | WHO classification and/or the use of neuropathic pain medication | 3 weeks |
| Pain medication | WHO classification and/or the use of neuropathic pain medication |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
The study population consists of patients with chronic back and/or leg pain who have been approved by the multidisciplinary team for SCS treatment.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mark Plazier, MD,PhD | Contact | +3211335511 | mark.plazier@jessazh.be | |
| Vincent Raymaekers, MD | Contact | +3211335511 | vincent.raymaekers@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Mark Plazier, MD,PhD | Jessa Hospital Hasselt, Belgium | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jessa Hospital | Recruiting | Hasselt | Belgium |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38054386 | Derived | Raymaekers V, Meeuws S, Goudman L, der Steen GV, Moens M, Vanloon M, Ridder D, Menovsky T, Vesper J, Plazier M. Patient profiling and outcome assessment in spinal cord stimulation for chronic back and/or leg pain (the PROSTIM study): a study protocol. Pain Manag. 2023 Dec;13(12):677-687. doi: 10.2217/pmt-2023-0103. Epub 2023 Dec 6. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D055111 | Failed Back Surgery Syndrome |
| D059350 | Chronic Pain |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001416 | Back Pain |
Not provided
Not provided
| ID | Term |
|---|---|
| D062187 | Spinal Cord Stimulation |
| ID | Term |
|---|---|
| D004599 | Electric Stimulation Therapy |
| D013812 | Therapeutics |
| D026741 | Physical Therapy Modalities |
| D012046 | Rehabilitation |
Not provided
Not provided
Not provided
Not provided
Not provided
| Health-related quality of life |
EQ-5D-3L |
| 3 weeks |
| Health-related quality of life | EQ-5D-3L | 6 months |
| Health-related quality of life | EQ-5D-3L | 12 months |
| 6 months |
| Pain medication | WHO classification and/or the use of neuropathic pain medication | 12 months |
| Spinal cord stimulation type | Type of spinal cord stimulation amongst different patient clusters | 3 weeks |
| Spinal cord stimulation type | Type of spinal cord stimulation amongst different patient clusters | 6 months |
| Spinal cord stimulation type | Type of spinal cord stimulation amongst different patient clusters | 12 months |
| Satisfied with current treatment | Yes/No question | 3 weeks |
| Satisfied with current treatment | Yes/No question | 6 months |
| Satisfied with current treatment | Yes/No question | 12 months |
| Rate of return to work | % of patients returning to work or daily activities | 3 weeks |
| Rate of return to work | % of patients returning to work or daily activities | 6 months |
| Rate of return to work | % of patients returning to work or daily activities | 12 months |
| Sint-Franciscus Ziekenhuis | Recruiting | Heusden-Zolder | Belgium |
| St. Trudo Ziekenhuis | Recruiting | Sint-Truiden | Belgium |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |